ALFA FinderBSE filing, NSE: 5PAISA. Summary written from the filing by ALFA Finder's alert engine.
5Paisa Capital Ltd: key numbers
- Share price
- ₹339.10
- Market cap
- ₹1,659 Cr
- Revenue (annual)
- ₹319.6 Cr
- Net profit (annual)
- ₹44.18 Cr
- P/E (TTM)
- 39.7×Sector 21.0×
- Promoter holding
- 36.50%+0.00% QoQ
- FII holding
- 15.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from 5Paisa Capital Ltd
All →5Paisa Capital Management Change
5Paisa Capital appointed Ms. Devi Yesodharan as Chief Content and Research Officer effective November 13, 2026. She brings 21+ years of experience from Trendlyne, Infosys, and other firms to the Senior Management role.
5Paisa Capital Preferential Issue
5paisa allotted 20,50,588 preferential equity shares at ₹380 each for Giskard Datatech shares. The allotment aggregates ₹77.92 Crore, paid via share swap.
- Value
- ₹77.92 Cr
5Paisa Capital Acquisition Worth ₹77.92 Cr
5paisa Capital's share-swap acquisition raised its Giskard Datatech stake to 57.41%, making it a subsidiary. The stated consideration is ₹77.92 Crore in equity shares.
- Value
- ₹77.92 Cr
5Paisa Capital Legal & Regulatory
5paisa Capital Ltd received a favourable income tax order for AY 2023-24, granting relief of ₹40.03 crore against a total disputed amount of ₹42.90 crore.
- Value
- ₹40.03 Cr
5Paisa Capital Legal & Regulatory
5paisa Capital's appeal against an Income Tax order for A.Y. 2023-24 was partly allowed, granting the company relief of ₹40.03 Crore.
- Value
- ₹42.90 Cr
5Paisa Capital Other Announcement
5paisa Capital Limited submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report confirms full utilization of the Rs. 468.82 Crore rights issue proceeds.
- Value
- ₹468.8 Cr
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr
Capri Global Capital Other Announcement
Capri Global Capital filed its monthly RBI ALM statement (structural liquidity and interest rate sensitivity) for October 2026, unaudited. This is a routine regulatory return with no new financing or corporate event.